Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    An NIH notice about its website transition and updated terminology appears above the page, while the clinical trial record still displays a 403 Forbidden error. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:30:03.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error screen HTML and related elements, addressing a core access issue that previously blocked viewing the study details. This change suggests the page can render the study details normally without displaying an error screen.
    Difference
    0.5%
    Check dated 2026-09-30T00:46:11.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a basic header and a Home link, and a large set of study-related documents and metadata are removed from the listing.
    Difference
    20%
    Check dated 2026-09-23T00:37:34.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an update to the page's revision history template rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T23:58:11.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6, replacing v3.6.5. This indicates a small version update in the site's backend or UI without changing the study content shown.
    Difference
    0.1%
    Check dated 2026-09-01T20:56:27.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.